Legal & General Group PLC G1 Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 5,467 shares of GTHX stock, worth $39,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,467
Holding current value
$39,089
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.2 - $4.98 $12,027 - $27,225
5,467 New
5,467 $12,000
Q1 2023

May 15, 2023
SELL
$2.57 - $8.16 $23,677 - $75,178
-9,213 Reduced 79.62%
2,358 $6,000
Q4 2022

Feb 14, 2023
BUY
$5.19 - $13.5 $60,053 - $156,208
11,571 New
11,571 $62,000
Q2 2022

Aug 22, 2022
SELL
$4.04 - $8.51 $80,141 - $168,812
-19,837 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$7.6 - $11.02 $836 - $1,212
110 Added 0.56%
19,837 $150,000
Q4 2021

Feb 14, 2022
BUY
$10.16 - $16.17 $91,297 - $145,303
8,986 Added 83.66%
19,727 $201,000
Q3 2021

Nov 15, 2021
BUY
$13.16 - $22.47 $76,393 - $130,438
5,805 Added 117.61%
10,741 $144,000
Q2 2021

Aug 12, 2021
SELL
$19.57 - $26.32 $1,957 - $2,632
-100 Reduced 1.99%
4,936 $109,000
Q1 2021

May 17, 2021
BUY
$17.58 - $32.59 $8,016 - $14,861
456 Added 9.96%
5,036 $121,000
Q4 2020

Feb 12, 2021
SELL
$10.99 - $20.4 $1,989 - $3,692
-181 Reduced 3.8%
4,580 $83,000
Q3 2020

Nov 13, 2020
SELL
$11.55 - $23.75 $16,250 - $33,416
-1,407 Reduced 22.81%
4,761 $55,000
Q2 2020

Aug 14, 2020
BUY
$9.57 - $24.37 $363 - $926
38 Added 0.62%
6,168 $149,000
Q1 2020

May 14, 2020
SELL
$9.07 - $26.32 $14,049 - $40,769
-1,549 Reduced 20.17%
6,130 $68,000
Q4 2019

Feb 13, 2020
BUY
$20.54 - $31.0 $16,801 - $25,358
818 Added 11.92%
7,679 $203,000
Q3 2019

Nov 13, 2019
BUY
$22.78 - $40.58 $15,695 - $27,959
689 Added 11.16%
6,861 $157,000
Q2 2019

Aug 14, 2019
BUY
$16.03 - $31.1 $33,855 - $65,683
2,112 Added 52.02%
6,172 $189,000
Q4 2018

Feb 15, 2019
BUY
$16.51 - $51.33 $11,160 - $34,699
676 Added 19.98%
4,060 $78,000
Q3 2018

Nov 20, 2018
BUY
$43.15 - $67.97 $5,738 - $9,040
133 Added 4.09%
3,384 $177,000
Q2 2018

Aug 10, 2018
BUY
$35.06 - $51.17 $30,256 - $44,159
863 Added 36.14%
3,251 $141,000
Q1 2018

May 17, 2018
BUY
$19.05 - $41.76 $11,963 - $26,225
628 Added 35.68%
2,388 $88,000
Q4 2017

Feb 13, 2018
BUY
$19.01 - $26.2 $33,457 - $46,112
1,760
1,760 $35,000

Others Institutions Holding GTHX

# of Institutions
101
Shares Held
20.1M
Call Options Held
1.87M
Put Options Held
1.18M
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email